Illuminate Therapeutics
PrivateLast Round
Seed
Jun 1, 2025
Total Funding Raised
$75,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Illuminate Therapeutics is a biotechnology company developing a light-activated drug delivery and release (LADDR) platform for the targeted treatment of oncology and autoimmune diseases.
Sector
Real Estate & PropTech
Verticals
Home & Lifestyle, Facility Management, Energy Management
Business Model
B2C
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illuminate Therapeutics Comparables
Compare Illuminate Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NiteLites | 87% | |
| Lighthouse Outdoor Lighting | 86% | |
| World Class Outdoor Lighting | 84% | |
Illuminate Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2025 | ||||
| Grant | Apr 29, 2022 |
Illuminate Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Pennsylvania State University | Seed |
| General Inception | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors grew 259% MoM, reaching 647.
Illuminate Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Illuminate Therapeutics's valuation, stock price, and market status.